{"id":"W2398137018","doi":"10.1158/1557-3265.ovca15-b72","title":"Abstract B72: Long-term survival and outcome update on patients (pts) with recurrent ovarian cancer who received Ipilimumab post GVAX vaccine.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Medicine; Internal medicine; Ovarian cancer; Oncology; Cancer; Nivolumab; Cancer immunotherapy; Immunotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000312448,0.000232184,0.0004674091,0.0005429713,0.0002751804,0.0005822401,0.0001749175,0.000396182,0.001634525],"category_scores_gemma":[0.0004832699,0.00008450564,0.0004144828,0.0006890669,0.000133491,0.0003605928,0.0002414256,0.0004742411,0.0004436575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002761848,"about_ca_system_score_gemma":0.0001780138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001248439,"about_ca_topic_score_gemma":0.002691929,"domain_scores_codex":[0.999872,0.00003038979,0.00001832095,0.00002075091,0.00002846217,0.00003005517],"domain_scores_gemma":[0.9995932,0.00008174437,0.0001464158,0.00001720719,0.00005350742,0.0001079615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00551159,0.0003339853,0.9121921,0.0002484428,0.0002896188,0.001178988,0.0002067555,0.0004276395,0.002975789,0.00006546429,0.003508616,0.07306099],"study_design_scores_gemma":[0.0003216184,0.004258382,0.9818385,0.0000859846,0.0004828569,0.003457045,0.0001770112,0.0004612946,0.0009482331,0.00008522764,0.007866634,0.00001722679],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833753,0.007718997,0.0003282287,0.0005628227,0.00003944651,0.00005823838,0.00339852,0.00003701666,0.004481503],"genre_scores_gemma":[0.9909859,0.00225157,0.0002291591,0.0002816255,0.0001347014,0.00004824817,0.005127442,0.000005311114,0.0009360474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001634525,"threshold_uncertainty_score":0.005468071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1546368663263597,"score_gpt":0.4801985841144167,"score_spread":0.3255617177880571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}